See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Oct. 16, 2007

Neurologic Disorders Diabetic Neuropathy Migraine (Pediatric)

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

Neurologic Disorders

Many people at risk of cognitive decline are not able to make visits to a medical clinic, due to factors such as lack of transportation, impaired mobility, and cost. This study will assess ways to evaluate cognitive function at a person's residence. Participants must be 75 or older, and additional criteria apply.

The research site is in Sun City, Ariz.

More information

Please see http://www.centerwatch.com/patient/studies/cat278.html.

-----

Diabetic Neuropathy

This eight-month study will evaluate an investigational medication for diabetic neuropathy. You must be diabetic and 18 or older to qualify. Participants will receive study related medical care and investigational medication at no cost, and may be compensated for time and travel.

The research site is in Dallas, Texas.

More information

Please see http://www.centerwatch.com/patient/studies/cat253.html.

-----

Migraine (Pediatric)

If you have a child aged 12 to 17 who has migraine headaches, the child may be eligible to participate in a study evaluating an investigational combination of two medications. Participants will receive study related exams and study medications at no cost, and may be compensated for time and travel.

The research site is in San Antonio, Texas.

More information

Please see http://www.centerwatch.com/patient/studies/cat440.html.

-----

Copyright 2007 Thomson CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.